HRP20090380T1 - SUPSTITUIRANI 1H-PIROLO[3,2-b, 3,2-c, i 2,3-c]PIRIDIN-2-KARBOKSAMIDI I SRODNI ANALOZI KAO INHIBITORI KAZEIN-KINAZE Iε - Google Patents

SUPSTITUIRANI 1H-PIROLO[3,2-b, 3,2-c, i 2,3-c]PIRIDIN-2-KARBOKSAMIDI I SRODNI ANALOZI KAO INHIBITORI KAZEIN-KINAZE Iε Download PDF

Info

Publication number
HRP20090380T1
HRP20090380T1 HR20090380T HRP20090380T HRP20090380T1 HR P20090380 T1 HRP20090380 T1 HR P20090380T1 HR 20090380 T HR20090380 T HR 20090380T HR P20090380 T HRP20090380 T HR P20090380T HR P20090380 T1 HRP20090380 T1 HR P20090380T1
Authority
HR
Croatia
Prior art keywords
pyrrolo
pyridine
carboxylic acid
alkyl
acid amide
Prior art date
Application number
HR20090380T
Other languages
English (en)
Croatian (hr)
Inventor
A. Metz William
Halley Franck
Dutruc-Rosset Gilles
Mi Choi-Sledeski Yong
B. Poli Gregory
M. Fink David
Doerflinger Gilles
Huang Bao-Guo
Marie Gelormini Ann
A. Gamboa Juan
Giovanni Andrew
E. Roehr Joachim
T. Tsay Joseph
Camacho Fernando
J. Hurst William
W. Harnish Stephen
Chiang Yulin
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of HRP20090380T1 publication Critical patent/HRP20090380T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20090380T 2003-12-11 2004-12-01 SUPSTITUIRANI 1H-PIROLO[3,2-b, 3,2-c, i 2,3-c]PIRIDIN-2-KARBOKSAMIDI I SRODNI ANALOZI KAO INHIBITORI KAZEIN-KINAZE Iε HRP20090380T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52876403P 2003-12-11 2003-12-11
PCT/US2004/040080 WO2005061498A1 (en) 2003-12-11 2004-12-01 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number Publication Date
HRP20090380T1 true HRP20090380T1 (hr) 2009-08-31

Family

ID=34710096

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090380T HRP20090380T1 (hr) 2003-12-11 2004-12-01 SUPSTITUIRANI 1H-PIROLO[3,2-b, 3,2-c, i 2,3-c]PIRIDIN-2-KARBOKSAMIDI I SRODNI ANALOZI KAO INHIBITORI KAZEIN-KINAZE Iε

Country Status (20)

Country Link
US (2) US7402672B2 (de)
EP (1) EP1747220B1 (de)
JP (1) JP4691506B2 (de)
KR (1) KR20060113754A (de)
CN (1) CN100439367C (de)
AT (1) ATE428711T1 (de)
AU (1) AU2004303826A1 (de)
BR (1) BRPI0417520A (de)
CA (1) CA2549183A1 (de)
DE (1) DE602004020685D1 (de)
DK (1) DK1747220T3 (de)
ES (1) ES2324871T3 (de)
HR (1) HRP20090380T1 (de)
IL (1) IL175875A0 (de)
PL (1) PL1747220T3 (de)
PT (1) PT1747220E (de)
RS (1) RS50823B (de)
SI (1) SI1747220T1 (de)
TW (1) TW200530234A (de)
WO (1) WO2005061498A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2724B1 (en) * 2004-08-19 2013-09-15 افينتس فارماسوتيكالز انك 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors
JO2629B1 (en) 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
ES2334927T3 (es) 2004-08-19 2010-03-17 Aventis Pharmaceuticals Inc. Derivados de 3-ariltioindol-2-carboxamida y sus analogos como imhibidores de caseina quinasa i.
AU2006284751A1 (en) * 2005-09-01 2007-03-08 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
CA2626789A1 (en) * 2005-10-21 2007-04-26 Exelixis, Inc. Pyrimidinones as casein kinase ii (ck2) modulators
FR2918061B1 (fr) 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
FR2918986B1 (fr) * 2007-07-19 2009-09-04 Sanofi Aventis Sa Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
FR2939134A1 (fr) 2008-12-01 2010-06-04 Sanofi Aventis Derives de 6-cycloamino-3-(1h-pyrrolo°2,3-b!pyridin-4-yl) imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique
FR2940285A1 (fr) 2008-12-19 2010-06-25 Sanofi Aventis Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo °1,2-b!-pyridazine et 6-cycloamino-2-furanyl-3- (pyridin-4-yl)imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique
FR2940284B1 (fr) 2008-12-19 2011-02-18 Sanofi Aventis Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2945289A1 (fr) 2009-05-11 2010-11-12 Sanofi Aventis Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
WO2014111871A1 (en) 2013-01-17 2014-07-24 Aurigene Discovery Technologies Limited 4,5-dihydroisoxazole derivatives as nampt inhibitors
WO2014182033A1 (en) * 2013-05-08 2014-11-13 Yuhan Corporation Process for the preparation of pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof
KR101657599B1 (ko) * 2013-05-20 2016-09-19 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
UY35834A (es) * 2013-11-14 2015-05-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
CN104974082A (zh) * 2015-07-26 2015-10-14 陈吉美 一种2-甲基-4-溴吡啶的制备方法
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
US10973820B2 (en) 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
WO2026062521A2 (en) 2024-09-18 2026-03-26 Institute Of Molecular And Clinical Ophthalmology Basel (Iob) Methods and compounds for promoting survival of photoreceptors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
BR9405737A (pt) 1993-02-24 1995-12-05 Merck & Co Inc Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
US6075037A (en) 1994-06-09 2000-06-13 Smithkline Beecham Corporation Endothelin receptor antagonists
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
CZ2004408A3 (cs) 2001-10-02 2005-03-16 Pharmacia & Upjohn Company Azabicyklicky substituované kondenzované heteroarylsloučeniny
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
DE60309852T2 (de) * 2002-03-27 2007-06-06 Glaxo Group Ltd., Greenford Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden

Also Published As

Publication number Publication date
CN100439367C (zh) 2008-12-03
US20050131012A1 (en) 2005-06-16
WO2005061498A1 (en) 2005-07-07
DK1747220T3 (da) 2009-08-10
JP4691506B2 (ja) 2011-06-01
PT1747220E (pt) 2009-07-08
ES2324871T3 (es) 2009-08-18
AU2004303826A1 (en) 2005-07-07
SI1747220T1 (sl) 2009-08-31
EP1747220A1 (de) 2007-01-31
EP1747220B1 (de) 2009-04-15
IL175875A0 (en) 2006-10-05
BRPI0417520A (pt) 2007-03-06
ATE428711T1 (de) 2009-05-15
TW200530234A (en) 2005-09-16
DE602004020685D1 (de) 2009-05-28
JP2007513950A (ja) 2007-05-31
PL1747220T3 (pl) 2009-09-30
KR20060113754A (ko) 2006-11-02
US20080200496A1 (en) 2008-08-21
CA2549183A1 (en) 2005-07-07
CN1906194A (zh) 2007-01-31
US7626027B2 (en) 2009-12-01
US7402672B2 (en) 2008-07-22
HK1098742A1 (en) 2007-07-27
RS50823B (sr) 2010-08-31

Similar Documents

Publication Publication Date Title
ES2380395T3 (es) Triazolopiridinas como inhibidores de fosfodiesterasa para el tratamiento de enfermedades dérmicas
JP6285013B2 (ja) ３，５−（非）置換−１Ｈ−ピロロ［２，３−ｂ］ピリジン、１Ｈ−ピラゾロ［３，４−ｂ］ピリジン、及び５Ｈ−ピロロ［２，３−ｂ］ピラジン、ＩＴＫ及びＪＡＫ３キナーゼの阻害剤
US6432989B1 (en) Use of CRF antagonists to treat circadian rhythm disorders
US7368459B2 (en) Heterocyclic compounds
JP4309653B2 (ja) 新規なスルホンアミド置換ピラゾロピリジン誘導体
US20030158195A1 (en) 1,6 naphthyridines useful as inhibitors of SYK kinase
RU2005131167A (ru) Ингибиторы цитокинов
KR20170103838A (ko) 염증 및 암의 치료를 위한 헤테로시클릭 itk 저해제
WO2012167600A1 (zh) 一种杂环并吡啶酮类化合物，其中间体、制备方法和用途
AR060316A1 (es) Azaindoles de utilidad como inhibidores de janus quinasas
SK89596A3 (en) Tricyclic compounds, pharmaceutical compositions on their base and prevention method of blastocyst implatation
WO2015008861A1 (ja) 新規イミダゾピリジン化合物
WO2020097258A1 (en) Pyridazinone compounds and uses thereof
JP2004517827A (ja) 新規なカルバメート置換ピラゾロピリジン誘導体
RU2016130932A (ru) Производные хинолона как ингибиторы рецептора фактора роста фибробластов
AU2017203986B2 (en) Novel furanone derivative
RU2008141239A (ru) Соединения тетрагидропиридотиенопиримидина и способы их применения
MX2011000330A (es) Derivados de piridino-piridinonas, su preparacion y su uso en terapeutica.
CA2729552A1 (en) Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
AU2013235344A1 (en) Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
CA2431326A1 (en) Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
ES2868973T3 (es) Derivados de cromano, isocromano y dihidroisobenzofurano como moduladores alostéricos negativos para mGluR2, composiciones y su uso
CA2285388A1 (en) Compounds
KR20200128394A (ko) 2,4-디아미노퀴나졸린 유도체 및 이의 의학적 용도
JP2016132649A (ja) 新規イミダゾピリジン誘導体およびその医薬用途